NXGL insider Adam R. Levy reports 4,000-share sale; 371,692 held
Rhea-AI Filing Summary
NEXGEL (NXGL) CEO and director Adam R. Levy disclosed open‑market sales executed under a Rule 10b5‑1 trading plan.
He sold 1,600 shares on 10/02/2025 at $2.5000 per share and 2,400 shares on 10/03/2025 at a weighted average price of $2.5497, with individual trades ranging from $2.5000 to $2.6100. After these transactions, he beneficially owned 371,692 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,000 shares
Net Sell
2 txns
Insider
Levy Adam R.
Role
Chief Executive Officer
Sold
4,000 shs ($10K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,400 | $2.5497 | $6K |
| Sale | Common Stock | 1,600 | $2.50 | $4K |
Holdings After Transaction:
Common Stock — 371,692 shares (Direct)
Footnotes (3)
- F1. The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan instituted for tax planning purposes. The shares were originally acquired by the Reporting Person from the Issuer on October 15, 2019
- F2. The Reporting Person sold all 1,600 shares of common stock in the open market at a price of $2.5000 per share.
- F3. Represents the weighted average of open market sale transactions ranging from $2.500 to $2.6100 per share. The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price sold if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did NXGL report?
The CEO and director, Adam R. Levy, reported open‑market sales executed under a Rule 10b5‑1 trading plan.
Were these NXGL insider sales part of a prearranged plan?
Yes. The filing states the sales were pursuant to a Rule 10b5‑1 plan instituted for tax planning purposes.